Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 21.4915.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 21.49 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,110.8 Cr -1.1% -4.5% -20.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1% 3.3% 14.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0% 10% 45.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,043.0 Cr -2% -0.6% -6.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.1%

-4.5%

-20.3%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses